Online Trial Tracker - Larvol Sigma

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Simulect (basiliximab) / Novartis

NCT00790439: Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant

Withdrawn

Low Molecular Weight Sulfated Dextran, LMW-SD, Heparin, Heparin Sodium, Mycophenolate Mofetil, MMF, Mycophenolate, Mycophenolic Acid, CellCept, Sirolimus, Rapamune, Tacrolimus, Hecoria, Cyclosporine, Ciclosporin, GENGRAF® Capsules, Daclizumab, Basiliximab, Simulect ®, Allogeneic Pancreatic Islet Cells

National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Diabetes Mellitus, Type I

10/09

NCT00434850: Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes

Completed

Allogeneic Pancreatic Islet Cells, Deoxyspergualin, Antithymocyte globulin, Daclizumab or basiliximab, Sirolimus, Tacrolimus, Etanercept

National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Diabetes Mellitus, Type 1

09/11

11/13

NCT00464555: Strategies to Improve Islet Survival

Completed

Islet transplant, Antithymocyte globulin, Basiliximab, Lisofylline, Sirolimus, Tacrolimus

National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Type 1 Diabetes Mellitus

11/11

02/14

LEEP, NCT00468403: LEA29Y (Belatacept) Emory Edmonton Protocol

Completed

US, Canada

Allogeneic Pancreatic Islet Cells, Belatacept, NUJOLIX, Basiliximab, Simulect, Mycophenolate Mofetil, Cellcept, Tacrolimus, Prograf, Intraportal infusion of islet cells

National Institute of Allergy and Infectious Diseases (NIAID), Clinical Islet Transplantation Consortium

Type 1 Diabetes Mellitus

04/12

04/13



	Diseases Companies Products Productz Mechanisms of Action Sites